Plantago squarrosa Murray extracts inhibit the growth of some bacterial triggers of autoimmune diseases: GC–MS analysis of an inhibitory extract
- 16 November 2018
- journal article
- research article
- Published by Springer Nature in Inflammopharmacology
- Vol. 27 (2) , 373-385
Abstract
Ankylosing spondylitis, multiple sclerosis, rheumatoid arthritis and rheumatic fever are autoimmune inflammatory diseases that may be triggered in genetically susceptible individuals by specific bacterial pathogens. Inhibiting the growth of these bacteria with high antioxidant plant extracts may inhibit the aetiology of these diseases, as well as inhibiting the later phase symptoms. P. squarrosa extracts were analysed for antioxidant activity using a DPPH free radical scavenging assay. Bacterial growth inhibitory activity was evaluated using disc diffusion assays and the activity was quantified by MIC determination. The extracts were screened for toxicity by A. franciscana nauplii assays. The most potent antibacterial extract (ethyl acetate) was analysed by GC–MS headspace profile analysis and compounds were identified with reference to a phytochemical database. All extracts displayed strong DPPH radical scavenging activity. The ethyl acetate extract was particularly potent (IC50 1.4 µg/mL), whilst the other extracts also had significant radical scavenging activity (IC50 values between 11 and 22 µg/mL). Notably, the bacterial growth inhibitory activity of the extracts correlated with their DPPH radical scavenging activity. The ethyl acetate extract, which had the greatest DPPH scavenging activity, generally displayed the most potent bacterial growth inhibitory activity. This extract was particularly potent against P. mirabilis, P. vulgaris and A. baylyi (MIC values of 484, 575 and 880 µg/mL, respectively). It also inhibited P. aeruginosa and S. pyogenes growth, albeit with higher MICs (1600–3700 µg/mL). All other extract–bacteria combinations were either inactive or resulted in mid–low potency inhibition. All extracts were non-toxic in the A. franciscana bioassay (LC50 substantially > 1000 µg/mL). In total, 89 unique mass signals were identified in the P. squarrosa ethyl acetate extract by non-biased GC–MS headspace analysis. A number of compounds which may contribute to the antibacterial activity of this extract have been highlighted.Keywords
This publication has 25 references indexed in Scilit:
- Identification of OppA2 Linear Epitopes as Serodiagnostic Markers for Lyme DiseaseClinical and Vaccine Immunology, 2014
- An examination of the medicinal potential of Scaevola spinescens: Toxicity, antibacterial, and antiviral activitiesPharmacognosy Research, 2011
- Terpenoids: natural inhibitors of NF-κB signaling with anti-inflammatory and anticancer potentialCellular and Molecular Life Sciences, 2008
- Human homologues of a Borrelia T cell epitope associated with antibiotic-refractory Lyme arthritisMolecular Immunology, 2008
- Rheumatoid Arthritis is an Autoimmune Disease Triggered by Proteus Urinary Tract InfectionJournal of Immunology Research, 2006
- Cross-reactivity between related sequences found in Acinetobacter sp., Pseudomonas aeruginosa, myelin basic protein and myelin oligodendrocyte glycoprotein in multiple sclerosisJournal of Neuroimmunology, 2003
- Toxicity profiles of traditional disease modifying antirheumatic drugs for rheumatoid arthritisAnnals of the Rheumatic Diseases, 2003
- Lipoproteins from Borrelia burgdorferi Applied in Liposomes and Presented by Dendritic Cells Induce CD8+ T-Lymphocytes in VitroCellular Immunology, 2000
- Sequence similarity between HLA-DR1 and DR4 subtypes associated with rheumatoid arthritis and proteus/serratia membrane haemolysins.Annals of the Rheumatic Diseases, 1992
- Central and Peripheral Nervous System Demyelination After Infection With Mycoplasma pneumoniae: Evidence of an Autoimmune ProcessSouthern Medical Journal, 1991